Long Term Integrity Follow-up Evaluation

Guidant Corporation0 个研究点目标入组 372 人2002年3月

适应症Sudden Cardiac Death

概览

阶段: 不适用
干预措施: 未指定
疾病 / 适应症: Sudden Cardiac Death
发起方: Guidant Corporation
入组人数: 372
状态: 已完成
最后更新: 15年前

概览研究者入排标准结局指标相似试验

概览

简要总结

To document the performance of the Guidant ENDOTAK EZ and the RELIANCE defibrillation leads over 5 years.

详细描述

There are few prospective long term follow-up studies on implanted cardiac device (pacemaker/implantable cardioverter defibrillator (ICD)) survivability. This study will evaluate the long term performance (5 years) of the transvenous defibrillation leads (ENDOTAK ENDURANCE EZ and teh ENDOTAK RELIANCE. Data will be collected at implant, 1 and 6 months, 1,3 and 5 years.

注册库

clinicaltrials.gov

开始日期

2002年3月

结束日期

2010年1月

最后更新

15年前

研究类型

Observational

性别

All

研究者

发起方

Guidant Corporation

入排标准

入选标准

•Patients selected for Guidant ICD system implant, available for follow-up at the defined intervals

排除标准

•Patients enrolled in other studies, not available for follow-up, \< 18 yrs, unable to sign consent, life expectancy \< 1 year due to a medical condition